A Study of AK111 in Subjects With Moderate-to-severe Plaque Psoriasis

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2020
This is a Phase Ib clinical study of multiple dose escalation of AK111 in subjects with moderate-to-severe plaque psoriasis
Epistemonikos ID: 49b7bd172be20f826642fba3f2d55a3550613878
First added on: May 13, 2024